The determination of the genetic background of sexual development has
not only assisted in the explanation of intersex disorders, but also i
n the diagnosis and clinical management of affected individuals. The p
ossibilities and limitations of molecular genetic studies can be illus
trated by the example of androgen insensitivity syndromes. The search
for the underlying mutations within the androgen receptor gene is tech
nically possible even for large numbers of patients. The characterizat
ion of mutations can be performed with high specificity and sensitivit
y. While large gene defects are associated with complete loss of funct
ion of the receptor, point mutations with subsequent amino acid change
s are responsible for the phenotypic variability of the disease. Type
and location of the amino acid substitution may influence the clinical
appearance of the individual patient, but the phenotype can be highly
variable even with the same underlying mutation. This is probably due
to regulation mechanisms within the cell of which the androgen recept
or is only one, although important, part. Therefore, results of molecu
lar genetic testing have to be interpreted only in connection with cli
nical and laboratory findings. Further research will focus on the eluc
idation of the cellular mechanisms of androgen action in order to intr
oduce the results into the clinical management of patients with androg
en insensitivity.